Ruth Keri

Ruth Keri

Case Western Reserve University

H-index: 44

North America-United States

About Ruth Keri

Ruth Keri, With an exceptional h-index of 44 and a recent h-index of 28 (since 2020), a distinguished researcher at Case Western Reserve University, specializes in the field of Breast Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer

Remembering John H. Nilson, PhD (1950–2023).

Assessment of racial and ethnic disparities in environmental exposure-related cancer burden

Abstract 1264 Characterizing the role of SMC2 in normalized mammary epithelial cells

In Memoriam: John H. Nilson, PhD (1950–2023)

Spatial Transcriptomics Suggests That Alterations Occur in the Preneoplastic Breast Microenvironment of BRCA1/2 Mutation Carriers

Abstract PO3-26-09: A novel class of RNR inhibitors that induces genomic instability and breast cancer cell death without inducing overt toxicities

Targeting the mitotic kinase NEK2 potentiates CDK4/6 inhibitor efficacy in breast cancer

Ruth Keri Information

University

Position

Cleveland Clinic and

Citations(all)

7365

Citations(since 2020)

2469

Cited By

5821

hIndex(all)

44

hIndex(since 2020)

28

i10Index(all)

83

i10Index(since 2020)

48

Email

University Profile Page

Case Western Reserve University

Google Scholar

View Google Scholar Profile

Ruth Keri Skills & Research Interests

Breast Cancer

Top articles of Ruth Keri

Title

Journal

Author(s)

Publication Date

The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer

Cell Death & Differentiation

Chun-Peng Pai

Han Wang

Darcie D Seachrist

Neel Agarwal

Joshua A Adams

...

2024/4/16

Remembering John H. Nilson, PhD (1950–2023).

Endocrine News (Online)

Ruth A Keri

2024/1/13

Assessment of racial and ethnic disparities in environmental exposure-related cancer burden

Cancer Research

Jessica R Bobbitt

Fangzhou Liu

Jennifer Cullen

Ruth A Keri

2024/3/22

Abstract 1264 Characterizing the role of SMC2 in normalized mammary epithelial cells

Journal of Biological Chemistry

Madison Miles

Jessica Bobbitt

Ruth Keri

2024/3/1

In Memoriam: John H. Nilson, PhD (1950–2023)

Ruth A Keri

Joan S Jorgensen

Helai P Mohammad

Mary Hunzicker-Dunn

2024/2

Spatial Transcriptomics Suggests That Alterations Occur in the Preneoplastic Breast Microenvironment of BRCA1/2 Mutation Carriers

Molecular Cancer Research

Anthony Caputo

Kavya Vipparthi

Peter Bazeley

Erinn Downs-Kelly

Patrick McIntire

...

2024/2/1

Abstract PO3-26-09: A novel class of RNR inhibitors that induces genomic instability and breast cancer cell death without inducing overt toxicities

Cancer Research

Taylor Baker

Kristen Weber-Bonk

Wei Huang

Derek Taylor

Ruth Keri

2024/5/2

Targeting the mitotic kinase NEK2 potentiates CDK4/6 inhibitor efficacy in breast cancer

Cancer Research

Jessica R Bobbitt

Leslie Cuellar-Vite

Benjamin Bryson

Kristen Weber-Bonk

Ruth Keri

2023/4/4

TLE3 sustains luminal breast cancer lineage fidelity to suppress metastasis

Cancer research

Lindsey J Anstine

Parth R Majmudar

Amy Aponte

Salendra Singh

Ran Zhao

...

2023/4/4

The GR-PDK4 Axis of Evil: Hijacking a Stress SOS to Drive Metastasis

Endocrinology

Abhishek A Chakraborty

Ruth A Keri

2023/8

Abstract P1-13-11: YES1 is a targetable vulnerability for improving taxane response in triple-negative breast cancer

Cancer Research

Natasha Ingles

Katrina Piemonte

Salendra Singh

Kristen Weber-Bonk

Ruth Keri

2023/3/1

Chromatin organization and transcriptional programming of breast cancer cell identity

Jessica R Bobbitt

Darcie D Seachrist

Ruth A Keri

2023/8

Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction

Journal of Biological Chemistry

Katrina M Piemonte

Bryan M Webb

Jessica R Bobbitt

Parth R Majmudar

Leslie Cuellar-Vite

...

2023/7/1

Alterations in the preneoplastic breast microenvironment of BRCA1/2 mutation carriers revealed by spatial transcriptomics

bioRxiv

Anthony Caputo

Kavya Vipparthi

Peter Bazeley

Erinn Downs-Kelly

Patrick McIntire

...

2023/5/25

Abstract PD3-06: The SRC family kinase, YES1, controls chromosomal stability and promotes growth of triple negative breast cancer

Cancer Research

Katrina Piemonte

Elyse Donaubauer

Ruth Keri

2022/2/15

Abstract P2-06-02: The condensin core subunit, SMC2 (structural maintenance of chromosomes 2), is necessary for the growth and genomic stability of triple negative breast …

Cancer Research

Jessica Ventura

Bryan Webb

Ruth Keri

2022/2/15

Focal adhesion kinase provides a collateral vulnerability that can Be leveraged to improve mTORC1 inhibitor efficacy

Cancers

Leslie Cuellar-Vite

Kristen L Weber-Bonk

Fadi W Abdul-Karim

Christine N Booth

Ruth A Keri

2022/7/11

Targeting the MUVB complex or downstream G2/M proteins potentiates CDK4/6 inhibitor efficacy in breast cancer

Cancer Research

Leslie Cuellar-Vite

Kristen Weber-Bonk

Ruth A Keri

2022/6/15

ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis

Genes & diseases

Valery Adorno-Cruz

Andrew D Hoffmann

Xia Liu

Nurmaa K Dashzeveg

Rokana Taftaf

...

2021/7/1

Up to your NEK2 in CIN

Oncotarget

Darcie D Seachrist

Lindsey J Anstine

Ruth A Keri

2021/4/4

See List of Professors in Ruth Keri University(Case Western Reserve University)